RFG
REGN icon

Range Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Range Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-309
Closed -$220K – 201
2024
Q4 		$220K Buy
+309
New +$259K 0.1% 171
2024
Q3 		– Sell
-262
Closed -$275K – 160
2024
Q2 		$275K Buy
262
+24
+10% +$23.3K 0.14% 146
2024
Q1 		$229K Buy
+238
New +$226K 0.12% 156
2023
Q1 		– Sell
-287
Closed -$207K – 182
2022
Q4 		$207K Buy
+287
New +$212K 0.14% 159
2022
Q2 		– Sell
-369
Closed -$258K – 175
2022
Q1 		$258K Sell
369
-23
-6% -$14.6K 0.16% 145
2021
Q4 		$248K Sell
392
-29
-7% -$17.8K 0.16% 147
2021
Q3 		$255K Buy
421
+9
+2% +$5.59K 0.18% 139
2021
Q2 		$230K Buy
+412
New +$209K 0.17% 147

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return